+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Particle Therapy Market by Therapy Type, Components, System, Application Area, End User - Global Forecast to 2030- Product Image
Particle Therapy Market by Therapy Type, Components, System, Application Area, End User - Global Forecast to 2030- Product Image
Sale

Particle Therapy Market by Therapy Type, Components, System, Application Area, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674447
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The particle therapy market is advancing rapidly, transforming oncological care with precision-based solutions that address the pressing needs of cancer treatment modernization. As adoption expands across global healthcare systems, industry leaders and stakeholders are positioning for strategic advantage through technology, operational efficiency, and targeted investments.

Market Snapshot: Particle Therapy Market Growth and Outlook

The Particle Therapy Market grew from USD 1.07 billion in 2024 to USD 1.16 billion in 2025. It is expected to continue growing at a CAGR of 8.58%, reaching USD 1.76 billion by 2030. Market development is shaped by ongoing investment in clinical research and the expansion of infrastructure, making advanced treatments more accessible in established and emerging regions. The positive outlook reflects rising demand for precision oncology and continuous advancements in system capabilities.

Scope & Segmentation

  • Therapy Type: Heavy Ion Therapy, Proton Therapy
  • Components: Beam Transport System Components (Beam Monitor, Bending Magnets, Collimators), Cyclotrons & Synchrotrons Accelerators, Treatment Delivery Systems
  • System Configuration: Multi-Room Systems, Single-Room Systems
  • Application Area: Breast Cancer, Head and Neck Cancer, Lung Cancer, Pediatric Cancer, Prostate Cancer
  • End User: Private Hospitals, Public Hospitals, Research Institutions, Oncology Clinics, Radiotherapy Centers
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (selected major countries), Asia-Pacific (China, India, Japan, Australia, South Korea, and key Southeast Asian markets)
  • Key Companies Profiled: B dot Medical Inc., C-Rad AB, Elekta AB, Hitachi Ltd., Ion Beam Applications S.A, Koninklijke Philips N.V., Leybold by Atlas Copco Group, Mevion Medical Systems, Optivus Proton Therapy Inc., P-Cure Ltd, ProTom International Holding Corporation, Provision Healthcare LLC, PTW Freiburg GmbH, SAH Global LLC, Shanghai APACTRON Particle Equipment Co. Ltd., Shinva Medical Instrument Co. Ltd., Siemens Healthineers AG, Stantec Inc., Sumitomo Heavy Industries Ltd., Sun Nuclear Corporation by Mirion Technologies, Toshiba Corporation, Xstrahl Ltd.
  • Technologies in Focus: Proton beam therapy, heavy ion therapy, compact accelerators, real-time imaging, adaptive planning, modular beam delivery, AI-driven dose planning, remote monitoring platforms

Key Takeaways for Decision-Makers

  • The market’s evolution is marked by the transition from large-scale academic installations toward scalable, compact modular systems, making access feasible for regional hospitals and specialty clinics.
  • Adoption is driven by a heightened focus on treatment precision and operational efficiency, enabled by technology such as pencil beam scanning and adaptive planning that improves patient outcomes and enhances workflow.
  • Collaborative research, public-private partnerships, and robust clinical data accelerate regulatory approvals, expand reimbursement eligibility, and support broader clinical guideline integration.
  • Regional dynamics show strong activity in Asia-Pacific installations, while the Americas and Europe maintain leadership through innovation and funding commitments tailored to local healthcare structures.
  • Segmentation reveals a shift in investment priorities; new facilities target pediatric and complex tumor indications, while established centers diversify programs for broader clinical impact.
  • Manufacturers are optimizing supply chains and service capabilities to manage geopolitical risks and ensure continuity of care in a changing global environment.

Tariff Impact on the U.S. Particle Therapy Market

The introduction of 2025 United States import tariffs on key particle therapy equipment has increased capital expenditure for new and retrofit installations. In response, domestic manufacturers are expanding local production of accelerators and beam system components, mitigating procurement delays and supporting supply chain resilience. Facility planners are exploring phased or modular expansion strategies to minimize immediate financial impact, while continued reinvestment in domestic R&D is expected to drive future innovation and operational efficiency.

Methodology & Data Sources

This report integrates structured interviews with industry executives, clinical experts, and technical leaders, complemented by analysis of financial filings, clinical trial data, and regulatory announcements. Multi-source validation, peer-reviewed literature, and expert panel reviews underpin the accuracy and reliability of segmentation and trend analysis.

Why This Report Matters

  • Provides clear, actionable intelligence for capital planning, procurement, and long-term investment strategy in precision oncology markets.
  • Informs product development and partnership decisions by illuminating key trends in technology adoption and evolving end-user requirements.
  • Delivers a comprehensive market segmentation that empowers stakeholders to tailor competitive strategies for both mature and emerging geographies.

Conclusion

The particle therapy market is entering an accelerated phase of growth, supported by advances in technology, strategic collaborations, and adaptive supply chain strategies. Stakeholders equipped with robust market intelligence will be positioned to drive innovation, expand patient access, and lead in precision cancer care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Particle Therapy Market, by Therapy Type
8.1. Introduction
8.2. Heavy Ion Therapy
8.3. Proton Therapy
9. Particle Therapy Market, by Components
9.1. Introduction
9.2. Beam Transport System Components
9.2.1. Beam Monitor
9.2.2. Bending Magnets
9.2.3. Collimators
9.3. Cyclotrons & Synchrotrons Accelerators
9.4. Treatment Delivery Systems
10. Particle Therapy Market, by System
10.1. Introduction
10.2. Multi-Room Systems
10.3. Single-Room Systems
11. Particle Therapy Market, by Application Area
11.1. Introduction
11.2. Breast Cancer
11.3. Head And Neck Cancer
11.4. Lung Cancer
11.5. Pediatric Cancer
11.6. Prostate Cancer
12. Particle Therapy Market, by End User
12.1. Introduction
12.2. Hospitals
12.2.1. Private Hospitals
12.2.2. Public Hospitals
12.3. Research Institutions
12.4. Specialty Clinics
12.4.1. Oncology Clinics
12.4.2. Radiotherapy Centers
13. Americas Particle Therapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Particle Therapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Particle Therapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. B dot Medical Inc.
16.3.2. C-Rad AB
16.3.3. Elekta AB
16.3.4. Hitachi, Ltd.
16.3.5. Ion Beam Applications S.A
16.3.6. Koninklijke Philips N.V.
16.3.7. Leybold by Atlas Copco Group
16.3.8. Mevion Medical Systems
16.3.9. Optivus Proton Therapy, Inc.
16.3.10. P-Cure Ltd
16.3.11. ProTom International Holding Corporation
16.3.12. Provision Healthcare, LLC
16.3.13. PTW Freiburg GmbH
16.3.14. SAH Global LLC
16.3.15. Shanghai APACTRON Particle Equipment Co., Ltd.
16.3.16. Shinva Medical Instrument Co., Ltd.
16.3.17. Siemens Healthineers AG
16.3.18. Stantec Inc.
16.3.19. Sumitomo Heavy Industries, Ltd.
16.3.20. Sun Nuclear Corporation by Mirion Technologies
16.3.21. Toshiba Corporation
16.3.22. Xstrahl Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PARTICLE THERAPY MARKET MULTI-CURRENCY
FIGURE 2. PARTICLE THERAPY MARKET MULTI-LANGUAGE
FIGURE 3. PARTICLE THERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM MONITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BENDING MAGNETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COLLIMATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS & SYNCHROTRONS ACCELERATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY TREATMENT DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD AND NECK CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PARTICLE THERAPY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PARTICLE THERAPY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PARTICLE THERAPY MARKET SIZE, BY RADIOTHERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 56. CANADA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 57. CANADA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 58. CANADA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 59. CANADA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. CANADA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 61. CANADA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 64. MEXICO PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 66. MEXICO PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 67. MEXICO PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. MEXICO PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 103. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 104. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 105. GERMANY PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 106. GERMANY PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 107. GERMANY PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 108. GERMANY PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. GERMANY PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 110. GERMANY PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 111. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 112. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 113. FRANCE PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 114. FRANCE PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 115. FRANCE PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 116. FRANCE PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. FRANCE PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 127. ITALY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 129. ITALY PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 130. ITALY PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 131. ITALY PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 132. ITALY PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. ITALY PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 134. ITALY PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 135. SPAIN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SPAIN PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 137. SPAIN PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 138. SPAIN PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 139. SPAIN PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 140. SPAIN PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. SPAIN PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. SPAIN PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 167. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 168. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 169. DENMARK PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 170. DENMARK PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 171. DENMARK PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 172. DENMARK PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. DENMARK PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 174. DENMARK PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 183. QATAR PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 185. QATAR PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 186. QATAR PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 187. QATAR PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 188. QATAR PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. QATAR PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. QATAR PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 191. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 193. FINLAND PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 194. FINLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 195. FINLAND PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 196. FINLAND PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. FINLAND PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 215. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 217. EGYPT PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 218. EGYPT PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 219. EGYPT PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 220. EGYPT PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. EGYPT PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. EGYPT PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 225. TURKEY PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 226. TURKEY PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 227. TURKEY PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 228. TURKEY PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. TURKEY PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 230. TURKEY PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 239. NORWAY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 241. NORWAY PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 242. NORWAY PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 243. NORWAY PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 244. NORWAY PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. NORWAY PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 247. POLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 248. POLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 249. POLAND PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 250. POLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 251. POLAND PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 252. POLAND PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. POLAND PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 254. POLAND PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 272. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 273. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 274. CHINA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 275. CHINA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 276. CHINA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 277. CHINA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. CHINA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 279. CHINA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 280. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 282. INDIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 283. INDIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 284. INDIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 285. INDIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. INDIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 287. INDIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 288. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 290. JAPAN PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 291. JAPAN PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 292. JAPAN PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 293. JAPAN PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. JAPAN PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 320. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 321. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 322. THAILAND PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 323. THAILAND PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 324. THAILAND PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 325. THAILAND PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. THAILAND PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 327. THAILAND PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE PARTICLE THERAPY MARKE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Particle Therapy market report include:
  • B dot Medical Inc.
  • C-Rad AB
  • Elekta AB
  • Hitachi, Ltd.
  • Ion Beam Applications S.A
  • Koninklijke Philips N.V.
  • Leybold by Atlas Copco Group
  • Mevion Medical Systems
  • Optivus Proton Therapy, Inc.
  • P-Cure Ltd
  • ProTom International Holding Corporation
  • Provision Healthcare, LLC
  • PTW Freiburg GmbH
  • SAH Global LLC
  • Shanghai APACTRON Particle Equipment Co., Ltd.
  • Shinva Medical Instrument Co., Ltd.
  • Siemens Healthineers AG
  • Stantec Inc.
  • Sumitomo Heavy Industries, Ltd.
  • Sun Nuclear Corporation by Mirion Technologies
  • Toshiba Corporation
  • Xstrahl Ltd.

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.76 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Particle Therapy - Global Strategic Business Report - Product Image

Particle Therapy - Global Strategic Business Report

  • Report
  • 83 Pages
  • Global
From
Particle Therapy Market Report 2025 - Product Image

Particle Therapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Particle Therapy Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Particle Therapy Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 151 Pages
  • Global
From
Particle Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Particle Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
NDDS in Cancer Therapy - Global Strategic Business Report - Product Image

NDDS in Cancer Therapy - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From

About the Particle Therapy Market

Particle therapy is a type of radiation therapy used to treat cancer. It uses beams of protons or other particles to deliver a precise dose of radiation to the tumor, minimizing damage to surrounding healthy tissue. This type of therapy is particularly useful for treating tumors located near sensitive organs, such as the brain, spinal cord, and eyes. It is also used to treat tumors that are difficult to reach with traditional radiation therapy. Particle therapy is becoming increasingly popular in the oncology drugs market, as it offers a more targeted approach to treating cancer. It is also associated with fewer side effects than traditional radiation therapy, making it a more attractive option for patients. Some of the companies in the particle therapy market include Varian Medical Systems, Elekta, IBA, Hitachi, and ProTom International. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.